Research on Breast Cancer Reoccurrence

This week, I’m providing my answer to a long-time reader who asked what I thought about taking the estrogen-receptor blocking medication letrozole in light of some side-effects she had. One of the important considerations is how much the medication will help prevent breast cancer reoccurrence. It just so happens that the American Society of Clinical Oncology had their annual meeting last week, and one of the papers presented addressed the issue of long-term use of letrozole (1). Here’s what the abstract said.

Researchers recruited close to 2,000 women who previously had early-stage . . .

We're sorry, but this content is available to Members and Insiders only.

If you're already a DrChet.com Member or Insider, click on the Membership Login link on the top menu. Members may upgrade to Insider by going to the Store and clicking Membership; your membership fee will be prorated automatically.